MedPath

Study to check the safety and performance of stent in all comer patients with de novo coronary artery disease .

Completed
Conditions
Chronic ischemic heart disease, unspecified,
Registration Number
CTRI/2022/12/048054
Lead Sponsor
Sahajanand Laser Technology Ltd
Brief Summary

A retrospective, single-arm, multi-center, observational, post-market clinical follow-up study to evaluate the safety and performance of FlexyRap Cobalt Chromium Rapamycin Eluting Coronary Stent System in patients with de novo coronary artery disease under real-world settings. The clinical endpoints are target lesion failure, cardiovascular death, target vessel myocardial infarction, clinically-driven target lesion revascularisation (CD-TLR), stent thrombosis (ST), target vessel failure (TVF), target vessel revascularization at 12 months, 3 years, 5 years follow-up. Total Number of 500 patients will be enrolled who have been implanted with FlexyRap Cobalt Chromium Rapamycin Eluting Coronary Stent .

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
500
Inclusion Criteria

All patients implanted with FlexyRap Cobalt Chromium Rapamycin Eluting Coronary Stent System.

Exclusion Criteria

Patients who are not implanted with FlexyRap Cobalt Chromium Rapamycin Eluting Coronary Stent System.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Target Lesion Failure which is defined as a composite of cardiovascular death, target vessel myocardial12 Months
infarction (TV-MI) and clinically driven target lesion revascularization12 Months
Secondary Outcome Measures
NameTimeMethod
Cardiovascular DeathTarget Vessel Myocardial Infarction

Trial Locations

Locations (5)

Cardinova Institute of Medical Science

🇮🇳

Jalandhar, PUNJAB, India

CAREMAX Hospital

🇮🇳

Jalandhar, PUNJAB, India

EMC Super Speciality Hospital

🇮🇳

Amritsar, PUNJAB, India

Moga Medicity Hospital

🇮🇳

Moga, PUNJAB, India

Sunshine Global Hospital

🇮🇳

Surat, GUJARAT, India

Cardinova Institute of Medical Science
🇮🇳Jalandhar, PUNJAB, India
Dr Nitish Garg
Principal investigator
9736088888
nitishgarg@yahoo.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.